Across TCGA pan-cancer cohorts, HNRNPCP6 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated HNRNPCP6 data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher HNRNPCP6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HNRNPCP6 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LAML show a favorable association.
UVM, ACC, and OV are the cancer types where HNRNPCP6 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.